Expert opinion on use of vagus nerve stimulation therapy in the management of pediatric epilepsy: a Delphi consensus study

Epilepsy is a common neurological disease characterized by recurrent seizures, affecting approximately 50 million individuals worldwide [1]. The estimated prevalence of epilepsy in the United States (US) in 2015 was three million adults and 470,000 children [2]. Approximately one-third of patients with epilepsy continue to have seizures after appropriate use of antiseizure medications (ASMs), a condition termed drug-resistant epilepsy (DRE) [3,4].

0